Q2e: one eMELT-iD and two Freemelt ONE deliveries Sales of SEK 13.
Suominen’s Q2 results are due Aug 9. H1 has low comparison figures, while H2 should also have scope ...
Redeye updates on EG7 following the weaker-than-expected Q2-results which looks to be related to a c...
Overall demand weakness, combined with customer-specific problems, led Scanfil to downgrade its 2024...
Redeye shares its initial comments on Xspray following the Dasynoc CRL.
Redeye has updated its estimates for Safeture following the Q2 2024 report, which was in line with o...
Redeye is hoping for a swift and robust solution to OXE Marine’s financial predicament.
Redeye is happy to see that Impact Coatings has received another order for an IC2000 fuel cell coati...
Redeye comments on EG7’s announcement of preliminary Q2-results which are below our expectations.
- Profitability yet to improve - Extrem Borr och Sågteknik added to numbers - Positive revision main...
Redeye leaves a note following Alzinova’s announcement of Carol Routledge having been appointed as t...
Vaisala’s Q2 was strong with solid volume growth, favorable sales mix in IM and continued OPEX disci...
Redeye comments on Sleep Cycle's Q2 2024 report, which came in slightly better on sales and EBIT tha...
We upgrade adjusted EBIT by 2-3% for 2024-26E, encouraged by a continued healthy North American mark...
- Optimism running high after another solid quarter - Positive long-term revisions, '26e EBIT up 1% ...
